Back to MORGAN STANLEY MORGAN STANLEY

LXEOLXEO
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in LEXEO THERAPEUTICS INC

MORGAN STANLEY holds 395,102 shares of LXEO (LEXEO THERAPEUTICS INC), worth $1.8M as of 2026-Q2. The position was decreased (-1.9% shares). LXEO represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$1.8M

Current Shares

395,102

Total Value Change

-$346,924

Total Shares Change

+153,274

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
395,102
-1.9%
$1.8M0.0%$4.66
0
2026-Q1
Increased
402,924
+187.4%
$2.3M0.0%$7.07
42
2025-Q4
Increased
140,181
+43.0%
$1.4M0.0%$9.74
34
2025-Q3
Increased
98,057
+15.7%
$651,0970.0%$6.66
19
2025-Q2
Increased
84,781
+0.6%
$340,8200.0%$4.12
16
2025-Q1
Increased
84,316
+12.7%
$292,5770.0%$4.10
18
2024-Q4
Decreased
74,828
-69.1%
$492,3680.0%$6.54
0
2024-Q3
Increased
241,828
+1809.7%
$2.2M0.0%$9.11
42

Other major holders of LXEO: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used